Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Exercise × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Motor Activity 7 Obesity 2 Neoplasms 2 Breast Neoplasms 2 Sarcopenia 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neurotoxicity Syndromes 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphedema 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Endometrial Neoplasms 1 Dementia 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Brain Neoplasms 1 Anomia 1 Alzheimer Disease 1

Interventions

Magnetic Resonance Spectroscopy 25 Specimen Handling 23 enzalutamide 21 Prednisone 19 Androgen Antagonists 15 Abiraterone Acetate 15 apalutamide 13 Pluvicto 10 darolutamide 9 Radiosurgery 9 Leuprolide 9 X-Rays 8 Radiotherapy 8 cabazitaxel 7 abiraterone 7 Photons 7 Biopsy 7 prednylidene 6 gallium 68 PSMA-11 6 deltacortene 6 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Glutamate Carboxypeptidase II 6 relugolix 5 luprolide acetate gel depot 5 bicalutamide 5 Goserelin 5 Docetaxel 5 Dexamethasone 5 Carboplatin 5 Brachytherapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06237179 2026-03-02

EXTRA-PC

Virginia Commonwealth University

Phase 1/2 Recruiting

Motor Activity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡